249 related articles for article (PubMed ID: 27286742)
1. Crystalline methamphetamine use and methamphetamine-related harms in Australia.
Degenhardt L; Sara G; McKetin R; Roxburgh A; Dobbins T; Farrell M; Burns L; Hall WD
Drug Alcohol Rev; 2017 Mar; 36(2):160-170. PubMed ID: 27286742
[TBL] [Abstract][Full Text] [Related]
2. The epidemiology of methamphetamine use and harm in Australia.
Degenhardt L; Roxburgh A; Black E; Bruno R; Campbell G; Kinner S; Fetherston J
Drug Alcohol Rev; 2008 May; 27(3):243-52. PubMed ID: 18368605
[TBL] [Abstract][Full Text] [Related]
3. Crystal methamphetamine smoking among regular ecstasy users in Australia: increases in use and associations with harm.
Kinner SA; Degenhardt L
Drug Alcohol Rev; 2008 May; 27(3):292-300. PubMed ID: 18368611
[TBL] [Abstract][Full Text] [Related]
4. Characteristics and harms associated with injecting versus smoking methamphetamine among methamphetamine treatment entrants.
McKetin R; Ross J; Kelly E; Baker A; Lee N; Lubman DI; Mattick R
Drug Alcohol Rev; 2008 May; 27(3):277-85. PubMed ID: 18368609
[TBL] [Abstract][Full Text] [Related]
5. Trends in methamphetamine use, markets and harms in Australia, 2003-2019.
Man N; Sisson SA; McKetin R; Chrzanowska A; Bruno R; Dietze PM; Price O; Degenhardt L; Gibbs D; Salom C; Peacock A
Drug Alcohol Rev; 2022 Jul; 41(5):1041-1052. PubMed ID: 35604870
[TBL] [Abstract][Full Text] [Related]
6. The epidemiology of ecstasy use and harms in Australia.
Degenhardt L; Roxburgh A; Dunn M; Campbell G; Bruno R; Kinner SA; George J; Quinn B; White N; Topp L
Neuropsychobiology; 2009; 60(3-4):176-87. PubMed ID: 19893334
[TBL] [Abstract][Full Text] [Related]
7. Amphetamine availability predicts amphetamine-related mental health admissions: A time series analysis.
Sara G; Baxter C; Menendez P; Lappin J
Aust N Z J Psychiatry; 2018 Nov; 52(11):1050-1056. PubMed ID: 29551076
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of injecting drug use and associated risk behavior among regular ecstasy users in Australia.
White B; Day C; Degenhardt L; Kinner S; Fry C; Bruno R; Johnston J
Drug Alcohol Depend; 2006 Jul; 83(3):210-7. PubMed ID: 16343810
[TBL] [Abstract][Full Text] [Related]
9. High-frequency drug purity and price series as tools for explaining drug trends and harms in Victoria, Australia.
Scott N; Caulkins JP; Ritter A; Quinn C; Dietze P
Addiction; 2015 Jan; 110(1):120-8. PubMed ID: 25220170
[TBL] [Abstract][Full Text] [Related]
10. Methamphetamine use among gay and bisexual men in Australia: Trends in recent and regular use from the Gay Community Periodic Surveys.
Lea T; Mao L; Hopwood M; Prestage G; Zablotska I; de Wit J; Holt M
Int J Drug Policy; 2016 Mar; 29():66-72. PubMed ID: 26851066
[TBL] [Abstract][Full Text] [Related]
11. Hospital separations for cannabis- and methamphetamine-related psychotic episodes in Australia.
Degenhardt L; Roxburgh A; McKetin R
Med J Aust; 2007 Apr; 186(7):342-5. PubMed ID: 17407429
[TBL] [Abstract][Full Text] [Related]
12. Health service utilisation attributable to methamphetamine use in Australia: Patterns, predictors and national impact.
McKetin R; Degenhardt L; Shanahan M; Baker AL; Lee NK; Lubman DI
Drug Alcohol Rev; 2018 Feb; 37(2):196-204. PubMed ID: 28294443
[TBL] [Abstract][Full Text] [Related]
13. Quite a lot of smoke but very limited fire--the use of methamphetamine in Europe.
Griffiths P; Mravcik V; Lopez D; Klempova D
Drug Alcohol Rev; 2008 May; 27(3):236-42. PubMed ID: 18368604
[TBL] [Abstract][Full Text] [Related]
14. Pills and pints: risky drinking and alcohol-related harms among regular ecstasy users in Australia.
Kinner SA; George J; Johnston J; Dunn M; Degenhardt L
Drug Alcohol Rev; 2012 May; 31(3):273-80. PubMed ID: 21919977
[TBL] [Abstract][Full Text] [Related]
15. 'Ice epidemic'? Trends in methamphetamine use from three Victorian surveillance systems.
Lim MS; Cogger S; Quinn B; Hellard ME; Dietze PM
Aust N Z J Public Health; 2015 Apr; 39(2):194-5. PubMed ID: 25559677
[No Abstract] [Full Text] [Related]
16. Recent trends in pharmaceutical drug use among frequent injecting drug users, frequent methamphetamine users and frequent ecstasy users in New Zealand, 2006-2009.
Wilkins C; Sweetsur P; Griffiths R
Drug Alcohol Rev; 2011 May; 30(3):255-63. PubMed ID: 21545555
[TBL] [Abstract][Full Text] [Related]
17. Patterns of drug dependence in a Queensland (Australia) sample of Indigenous and non-Indigenous people who inject drugs.
Smirnov A; Kemp R; Ward J; Henderson S; Williams S; Dev A; Najman JM
Drug Alcohol Rev; 2016 Sep; 35(5):611-9. PubMed ID: 27241554
[TBL] [Abstract][Full Text] [Related]
18. The War on Drugs: Methamphetamine, Public Health, and Crime.
Dobkin C; Nicosia N
Am Econ Rev; 2009 Mar; 99(1):324-349. PubMed ID: 20543969
[TBL] [Abstract][Full Text] [Related]
19. Disruption to Australian heroin, methamphetamine, cocaine and ecstasy markets with the COVID-19 pandemic and associated restrictions.
Price O; Man N; Sutherland R; Bruno R; Dietze P; Salom C; Agramunt S; Grigg J; Degenhardt L; Peacock A
Int J Drug Policy; 2023 Mar; 113():103976. PubMed ID: 36822010
[TBL] [Abstract][Full Text] [Related]
20. Meth/amphetamine use and associated HIV: Implications for global policy and public health.
Degenhardt L; Mathers B; Guarinieri M; Panda S; Phillips B; Strathdee SA; Tyndall M; Wiessing L; Wodak A; Howard J;
Int J Drug Policy; 2010 Sep; 21(5):347-58. PubMed ID: 20117923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
